Abbott advisory board invite: appeal overturns ‘promotional meeting’ finding, but disorganised invite process breached Clause 9.1

📅 8 March 2026 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/2063/10/07
ComplainantConsultant physician (anonymous to company)
CompanyAbbott Laboratories Limited
MatterInvitation to a renal care advisory board (Zemplar/paricalcitol)
Honorarium£500 for a 6-hour session (plus travel/accommodation if required)
Complaint received31 October 2007
Case completed30 January 2008
Applicable Code year2006
Panel decisionPanel initially ruled breaches of Clause 18.1 and Clause 9.1; no breach of Clause 2
AppealAppeal by respondent
Appeal Board decisionNo breach of Clause 18.1; breach of Clause 9.1 upheld; no breach of Clause 2
Breach clause(s)9.1
SanctionsUndertaking received; additional sanctions: Not stated

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A consultant physician complained about an invitation from Abbott to attend a renal care advisory board (Zemplar/paricalcitol) with an honorarium of £500 for a 6-hour session, plus travel/accommodation if required.
  • The complainant said they were not a leading expert in the relevant area and felt the invite looked like promotion/marketing rather than genuine clinical consultation.
  • The complainant received two copies of the invitation; one was blank and not signed.
  • The Panel raised concerns about whether the invitation made clear the honorarium was payment for work/advice, whether an agenda was sent, and whether the agenda allowed sufficient time for delegate input to justify the fee.
  • Abbott appealed.
  • On appeal, the Appeal Board accepted the meeting was a bona fide advisory board (not a promotional meeting), but identified serious process issues around how invitations were issued and tracked.
⚖️

Outcome

  • Appeal Board: No breach of Clause 18.1 (participants were being paid to attend an advisory board, not a promotional meeting).
  • Appeal Board: Breach of Clause 9.1 upheld due to a disorganised invitation process (including unexplained discrepancies in invite lists and unsigned/non-headed invitations).
  • No breach of Clause 2.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training